header logo
Vallibel FD
vallible LE
Latest
Three Ebola vaccines in development amid growing outbreak fears
Jun 01, 202609:27 PM
Three Ebola vaccines in development amid growing outbreak fears
Mobitel inner 1278

Three new vaccines are being developed to tackle the rare species of Ebola that has already killed nearly 250 people.

 

The International Aids Vaccine Initiative (IAVI), which is working on one vaccine, said the outbreak was threatening to be the worst ever.

 

The University of Oxford and the pharma company Moderna are also researching vaccines against the Bundibugyo species.

 

The Coalition for Epidemic Preparedness Innovations, which is providing funding to each group, said "every day counts".

 

There are now more than 1,000 suspected cases in the DR Congo with nine confirmed cases in neighbouring Uganda.

 

There is growing concern this outbreak – which was detected only after it had spread in a conflict zone with limited healthcare resources – could reach the size of the largest ever Ebola outbreak in West Africa in 2014-16. Then, nearly 29,000 people were infected and more than 11,000 died.

 

Dr Mark Feinberg, head of IAVI, said: “I think this is clearly threatening to be as severe an outbreak as that, if not even worse, and development of a vaccine, and other countermeasures, is clearly a priority.”

 

It echoes concerns from the medical charity Médecins Sans Frontières (MSF) which said the situation was "deeply alarming" and never before had "so many cases" been recorded so soon.

 

Vaccines must be developed for each individual species of Ebola – there are six, but only three are known to cause outbreaks.

 

There is a vaccine for the most common Zaire species, but this outbreak is being caused by another species, called Bundibugyo. It has only been seen twice before and there is no approved vaccine.

 

IAVI is working on a modified version of the Zaire Ebola vaccine to fight Bundibugyo. The experimental jab has been tested in monkeys where it rapidly trained the immune system and gave close to 100% protection.

 

Feinberg said their evidence so far meant he was "optimistic about the potential", but currently it would take seven to nine months to get the vaccine ready for clinical trials - although they are trying to "accelerate those timelines".

 

Meanwhile, the pharmaceutical company Moderna has announced it is using its mRNA technology – which was deployed to rapidly develop vaccines in the Covid pandemic – to work on Bundibugyo.

 

"We will move with urgency and scientific rigor to support the response and help bring a potential vaccine closer to the communities that need it most," said Stéphane Bancel, chief executive officer of Moderna.

 

And the University of Oxford has already said it is working on its own vaccine technology, which also saved lives in Covid, to develop a fresh Ebola vaccine.

 

This should be ready for clinical trials in two to three months.

 

Each vaccine aims to train the body to spot the same structure on the surface of the virus – known as the Bundibugyo glycoprotein. However, each uses a different technology to get there.

 

IAVI uses a live, but harmless virus that has been engineered so it also has the Ebola glycoprotein. The immune system fights off the harmless virus and learns to fight Ebola in the process.

 

The mRNA vaccine and the Oxford vaccine both deliver a snippet of genetic code into the body. Once inside it orders the construction of the Bundibugyo glycoprotein, which the body recognises as foreign and starts to attack.

 

All would mean that the immune system has a head start when it comes to fighting a real Ebola infection.

 

However, differences in the technologies and the way they train the immune system could affect levels of protection or the number of doses needed. All this needs to be tested in clinical trials.

 

The Coalition for Epidemic Preparedness Innovations (Cepi) is funding the early stages of research.

 

"With Bundibugyo virus spreading rapidly and no licensed vaccines, every day counts in the race against this deadly disease," said Dr Richard Hatchett, CEO of CEPI.

 

Dr Tedros Adhanom Ghebreyesus, the director general of the World Health Organization, said: “A Bundibugyo vaccine could help to control this epidemic and strengthen preparedness for future outbreaks.”

 

Source: BBC

– Agencies

Disclaimer: All the comments will be moderated by the AD editorial. Abstain from posting comments that are obscene, defamatory or slanderous. Please avoid outside hyperlinks inside the comment and avoid typing all capitalized comments. Help us delete comments that do not follow these guidelines by flagging them (mouse over a comment and click the flag icon on the right side). Do use these forums to voice your opinions and create healthy discourse.

Comments

0
Comments are disabled

Note: Due to legal constraints, the Ada Derana Editorial team has taken a decision to disable comments on all articles concerning ongoing court procedures.

MostRead
Mobitel 1278
VideoStories
 No issues concerning overall fuel supply or distribution Stocks secured until mid-2027

No issues concerning overall fuel supply or distribution Stocks secured until mid-2027

 Election Commission suspends SLFP’s status as a ‘recognized political party’ amidst major split

Election Commission suspends SLFP’s status as a ‘recognized political party’ amidst major split

 Detention period in Organised Crime Prevention Bill to be reduced from 72 to 48 hours – President

Detention period in Organised Crime Prevention Bill to be reduced from 72 to 48 hours – President

Government has not taken decisions harmful to public -- Dy Minister Mahinda Jayasinghe

Government has not taken decisions harmful to public -- Dy Minister Mahinda Jayasinghe

 Court orders freezing of bank accounts and vehicles belonging to Rakitha Rajapakshe for 3 months

Court orders freezing of bank accounts and vehicles belonging to Rakitha Rajapakshe for 3 months

Heroin and 'Ice' haul weighing over 150kg seized from vessel intercepted in southern seas

Heroin and 'Ice' haul weighing over 150kg seized from vessel intercepted in southern seas

 Protest against proposed PSTA and Organised Crime Prevention Bill marches towards Parliament

Protest against proposed PSTA and Organised Crime Prevention Bill marches towards Parliament

 The 3rd International Broadcaster’s Symposium to be held on Nov. 11 & 12 in Colombo

The 3rd International Broadcaster’s Symposium to be held on Nov. 11 & 12 in Colombo

 PUCSL recommends 1.46% electricity tariff hike for October–December 2026

PUCSL recommends 1.46% electricity tariff hike for October–December 2026

 Court to deliver decision on Gotabaya Rajapaksa's foreign travel ban on Nov. 25

Court to deliver decision on Gotabaya Rajapaksa's foreign travel ban on Nov. 25

PSTA draws widespread opposition from civil groups; Several protests planned against the Bill

PSTA draws widespread opposition from civil groups; Several protests planned against the Bill

Parliament heated over no-confidence motion against Speaker; SJB stages protest within the chamber

Parliament heated over no-confidence motion against Speaker; SJB stages protest within the chamber

 Namal Rajapaksa granted bail in Krrish bribery case based on exceptional circumstances by court

Namal Rajapaksa granted bail in Krrish bribery case based on exceptional circumstances by court

 "PSTA will cause serious damage to the country" Opposition says PSTA an attempt to suppress dissent

"PSTA will cause serious damage to the country" Opposition says PSTA an attempt to suppress dissent

 Crowds flock to IRD offices amid new TIN requirement; IRD urges public to avoid unnecessary visits

Crowds flock to IRD offices amid new TIN requirement; IRD urges public to avoid unnecessary visits

Lassana Flora